Cannabis firm Ayr Strategies (CSE:AYR.A,OTCQX:AYRSF) is looking to improve its standing in the industry through a share repurchase program.

On Tuesday (September 24), the multi-state operator (MSO) confirmed it will be authorizing a stock buyback of 5 percent, the maximum amount allowed by the Canadian Securities Exchange (CSE), where it is listed, over a 12 month period.


Starting on October 1, Ayr will begin buying a total of 725,892 subordinate voting shares. According to the firm, this action will be funded by cash flow generated from operations, which the MSO now projects to reach approximately US$1.7 million per month this year.

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

A share repurchase is a strategy companies use to buy back some or all of their outstanding shares with extra cash. Since it leaves fewer shares in the market, the stake of each investor increases in value.

Jonathan Sandelman, CEO of Ayr, said in a press release that the recent increase in cash flow for the company will give it the chance to “opportunistically repurchase” its stock for a worthwhile price, since the firm argues it is currently not valued appropriately.

Ayr’s chief operating officer, Jennifer Drake, told the Investing News Network (INN) that the current slump facing the industry has affected Ayr  forcing its share price down about 12 percent year-to-date  but it’s made the timing of this repurchase all the better for the company, since it can buy back its own shares at a reduced cost.

“We think … (Ayr) should be trading at a much higher multiple relative to the comparables, and so given the price action, we think this is a great time to be buying back what we think is one of the cheapest stocks in the sector,” the executive told INN.

Matthew Pallotta, equity research analyst at Echelon Wealth Partners, previously told INN that MSOs are facing a gap in valuations relative to the Canadian leaders of the public stock market.

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

“I think the discount is probably going to close regardless once people start seeing the revenue numbers these businesses are putting up,” Pallotta told INN.

Drake said Ayr’s investors will benefit from the increased value as a result of the repurchase.

According to Sandelman, the influx of cash for Ayr came during a run up in operations during the third quarter of 2019, giving the company the flexibility to buy back its shares.

The executive said the management of Ayr would have supported a repurchase of 10 percent worth of its shares, as is typical on other exchanges, but given the limitations from the CSE, 5 percent is all the company can buy back at this time.

“We believe repurchasing our shares represents one of the most attractive buying opportunities in the cannabis sector today, and this announcement reinforces our commitment to driving shareholder value.”

Sandelman added that the buying action will not affect the development path of the company.

Drake said Ayr is cash flow positive, a relative rarity in the cannabis space as companies in the nascent industry attempt to establish themselves under the weight of investor expectations. She added that Ayr plans on expanding its footprint across the US via consolidation strategies.

As part of its repurchase plan announcement, Ayr also adjusted its financial forecast for 2019.

Based on its results from Q3, the company increased the midpoint of its 2019 revenues and released an adjusted earnings before interest, tax, depreciation and amortization (EBITDA) estimate.

Ayr’s previous revenue projections were between US$110 million and US$130 million, but gains from the firm’s most recent quarter have shortened that range to US$120 million to US$130 million.

Ayr’s EBITDA for the fiscal 2019 year was altered to between US$35 million and US$40 million, from a previous range of US$30 million to US$40 million.

Ayr’s revenue in August was US$11.5 million, an 8.5 percent increase from July’s revenue of US$10.6 million and a 30.7 percent increase from the US$8.8 million in revenue reported in June.

In Ayr’s most recent financial results, the company reported it would be expanding production capacity at its Massachusetts facility due to increased demand. The MSO is also working on the vertical integration of its Nevada facility.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Danielle Edwards, hold no direct investment interest in any company mentioned in this article.

Editorial Disclosure: The Investing News Network does not guarantee the accuracy or thoroughness of the information reported in the interviews it conducts. The opinions expressed in these interviews do not reflect the opinions of the Investing News Network and do not constitute investment advice. All readers are encouraged to perform their own due diligence.

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

Codebase Ventures Inc. (“Codebase” or the “Company”) (CSE:CODE)(FSE:C5B)(OTCQB:BKLLF) is pleased to announce that it has issued a total of 7,400,000 options pursuant to its incentive stock option plan (“Plan”) to management, employees and consultants. Each option entitles the holder to subscribe for one common share of the Company for $0.265 for a period of 5 years, subject to the terms of the Plan

The Company has also agreed to engage Aktiencheck.de AG, for €50,000 for a European marketing and news dissemination program. The length of such program depends upon the Company’s future news flow.

Keep reading... Show less
  • Company has received UK Continuing Professional Development (“CPD”) accreditation for its global education platform, Khiron Academy
  • UK medical professionals may now earn CPD credits through Khiron’s medical cannabis education program
  • The Company has entered into a strategic partnership with Cellen Therapeutics, a leader in digital healthcare in the UK, to increase patient access via medical cannabis education
  • As a leading international medical cannabis educator, nearly 1,000 medical professionals in Latin America and the United Kingdom have registered for, or completed, Khiron Academy training

 Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN) (OTCQX: KHRNF) ( Frankfurt : A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe is pleased to announce it has received UK Continuing Professional Development (“CPD”) accreditation for Khiron Academy, the Company’s global medical cannabis education platform.

Additionally, following its accreditation, the Company has entered into a strategic partnership with Cellen Therapeutics, a leader in digital healthcare in the UK and fellow founding member of Project Twenty21, to increase patient access through medical cannabis education initially. Khiron Academy will be made available to prescribers in the UK that have registered with Cellen’s MedCanHub, an emerging education portal. Cellen is market leader, widely recognized for also launching the UK’s first digital pain clinic, Leva.

Keep reading... Show less

TRACE’s plant-based and alkaline wellness products to expand into key markets of Japan, China and the Philippines

Emerging leader in innovative health and wellness beverages and consumer products, BevCanna Enterprises Inc . ( CSE:BEV , Q:BVNNF , FSE:7BC ) (“ BevCanna ” or the “ Company ”) announces today its anticipated expansion into the Asia Pacific region, through its wholly-owned subsidiary Naturo Group. After completing a comprehensive market, distribution and partner assessment, the Company intends to initially launch its portfolio of TRACE health and wellness products in the key markets of Japan, China, and the Philippines, through multi-channel distribution outlets including e-commerce, retail, and wholesale.

Keep reading... Show less

Trulieve acquires dispensary permits from Solevo Wellness West Virginia LLC for $650,000

Trulieve Cannabis Corp . (CSE: TRUL) (OTCQX: TCNNF), a leading and top-performing cannabis company in the United States and the largest cannabis company in Florida announced today that it acquired Solevo Wellness West Virginia LLC (“Solevo”) and its three West Virginia dispensary permits for $650,000 . Solevo was awarded two permits in Morgantown and one in Parkersburg in January 2021 as part of the West Virginia application process.

Keep reading... Show less

Better Plant Sciences Inc. (CSE: PLNT) (OTCQB: VEGGF) (FSE: YG3) (“Better Plant”) or (the “Company”) a wellness company that develops and sells sustainable, plant-based products, is pleased to announce that it’s Jusu Home and Body line is now available for purchase on Faire Wholesale Marketplace (“Faire” or “www.faire.com”), an online wholesale marketplace valued at US $2.5 billion. Jusu Home and Body products are currently featured in their “New Arrivals” section.

Cannot view this image? Visit: https://orders.newsfilecorp.com/files/6377/80230_8c77c54544bf884c_001.jpg

Keep reading... Show less